468 related articles for article (PubMed ID: 24607601)
21. BLT humanized mice as a small animal model of HIV infection.
Karpel ME; Boutwell CL; Allen TM
Curr Opin Virol; 2015 Aug; 13():75-80. PubMed ID: 26083316
[TBL] [Abstract][Full Text] [Related]
22. Characterization of HIV-1 infection in the humanized Rag2-/-γc-/- mouse model.
Sanchez FM; Berges BK
Methods Mol Biol; 2013; 1031():215-22. PubMed ID: 23824904
[TBL] [Abstract][Full Text] [Related]
23. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.
Brehm MA; Cuthbert A; Yang C; Miller DM; DiIorio P; Laning J; Burzenski L; Gott B; Foreman O; Kavirayani A; Herlihy M; Rossini AA; Shultz LD; Greiner DL
Clin Immunol; 2010 Apr; 135(1):84-98. PubMed ID: 20096637
[TBL] [Abstract][Full Text] [Related]
24. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial.
Brendel C; Rio P; Verhoeyen E
Biochem Pharmacol; 2020 Apr; 174():113711. PubMed ID: 31726047
[TBL] [Abstract][Full Text] [Related]
25. Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice.
Long BR; Stoddart CA
J Virol; 2012 Mar; 86(6):3327-36. PubMed ID: 22238321
[TBL] [Abstract][Full Text] [Related]
26. Recent Updates on Mouse Models for Human Immunodeficiency, Influenza, and Dengue Viral Infections.
Krishnakumar V; Durairajan SSK; Alagarasu K; Li M; Dash AP
Viruses; 2019 Mar; 11(3):. PubMed ID: 30871179
[TBL] [Abstract][Full Text] [Related]
27. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
[TBL] [Abstract][Full Text] [Related]
28. Humanized mice for human retrovirus infection.
Koyanagi Y; Tanaka Y; Ito M; Yamamoto N
Curr Top Microbiol Immunol; 2008; 324():133-48. PubMed ID: 18481458
[TBL] [Abstract][Full Text] [Related]
29. Human cancer growth and therapy in immunodeficient mouse models.
Shultz LD; Goodwin N; Ishikawa F; Hosur V; Lyons BL; Greiner DL
Cold Spring Harb Protoc; 2014 Jul; 2014(7):694-708. PubMed ID: 24987146
[TBL] [Abstract][Full Text] [Related]
30. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.
Ishikawa F; Yasukawa M; Lyons B; Yoshida S; Miyamoto T; Yoshimoto G; Watanabe T; Akashi K; Shultz LD; Harada M
Blood; 2005 Sep; 106(5):1565-73. PubMed ID: 15920010
[TBL] [Abstract][Full Text] [Related]
31. Generation of improved mouse models for the study of hepatitis C virus.
Douglas DN; Kneteman NM
Eur J Pharmacol; 2015 Jul; 759():313-25. PubMed ID: 25814250
[TBL] [Abstract][Full Text] [Related]
32. Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model.
Ghosn S; Chamat S; Prieur E; Stephan A; Druilhe P; Bouharoun-Tayoun H
Front Immunol; 2018; 9():601. PubMed ID: 29628927
[TBL] [Abstract][Full Text] [Related]
33. Using the BLT humanized mouse as a stem cell based gene therapy tumor model.
Vatakis DN; Bristol GC; Kim SG; Levin B; Liu W; Radu CG; Kitchen SG; Zack JA
J Vis Exp; 2012 Dec; (70):e4181. PubMed ID: 23271478
[TBL] [Abstract][Full Text] [Related]
34. Humanized Rag1-/- γc-/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes.
Akkina R; Berges BK; Palmer BE; Remling L; Neff CP; Kuruvilla J; Connick E; Folkvord J; Gagliardi K; Kassu A; Akkina SR
PLoS One; 2011; 6(6):e20169. PubMed ID: 21695116
[TBL] [Abstract][Full Text] [Related]
35. Humanized mouse models of HIV infection.
Denton PW; García JV
AIDS Rev; 2011; 13(3):135-48. PubMed ID: 21799532
[TBL] [Abstract][Full Text] [Related]
36. Humanized SCID mouse models for biomedical research.
Pearson T; Greiner DL; Shultz LD
Curr Top Microbiol Immunol; 2008; 324():25-51. PubMed ID: 18481451
[TBL] [Abstract][Full Text] [Related]
37. Humanized Mouse Models for Human Immunodeficiency Virus Infection.
Marsden MD; Zack JA
Annu Rev Virol; 2017 Sep; 4(1):393-412. PubMed ID: 28746819
[TBL] [Abstract][Full Text] [Related]
38. Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies.
Xia X; Li H; Satheesan S; Zhou J; Rossi JJ
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30663638
[TBL] [Abstract][Full Text] [Related]
39. BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.
Lavender KJ; Pang WW; Messer RJ; Duley AK; Race B; Phillips K; Scott D; Peterson KE; Chan CK; Dittmer U; Dudek T; Allen TM; Weissman IL; Hasenkrug KJ
Blood; 2013 Dec; 122(25):4013-20. PubMed ID: 24021673
[TBL] [Abstract][Full Text] [Related]
40. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.
Shultz LD; Lang PA; Christianson SW; Gott B; Lyons B; Umeda S; Leiter E; Hesselton R; Wagar EJ; Leif JH; Kollet O; Lapidot T; Greiner DL
J Immunol; 2000 Mar; 164(5):2496-507. PubMed ID: 10679087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
